These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9602985)

  • 41. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
    Dove LS; Lembo A; Randall CW; Fogel R; Andrae D; Davenport JM; McIntyre G; Almenoff JS; Covington PS
    Gastroenterology; 2013 Aug; 145(2):329-38.e1. PubMed ID: 23583433
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Subject's Global Assessment of Relief: an appropriate method to assess the impact of treatment on irritable bowel syndrome-related symptoms in clinical trials.
    Müller-Lissner S; Koch G; Talley NJ; Drossman D; Rueegg P; Dunger-Baldauf C; Lefkowitz M
    J Clin Epidemiol; 2003 Apr; 56(4):310-6. PubMed ID: 12767407
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical trial: the efficacy of alverine citrate/simeticone combination on abdominal pain/discomfort in irritable bowel syndrome--a randomized, double-blind, placebo-controlled study.
    Wittmann T; Paradowski L; Ducrotté P; Bueno L; Andro Delestrain MC
    Aliment Pharmacol Ther; 2010 Mar; 31(6):615-24. PubMed ID: 20003095
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Randomised clinical trial: the clinical effects of a novel neurokinin receptor antagonist, DNK333, in women with diarrhoea-predominant irritable bowel syndrome.
    Zakko S; Barton G; Weber E; Dunger-Baldauf C; Rühl A
    Aliment Pharmacol Ther; 2011 Jun; 33(12):1311-21. PubMed ID: 21507028
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R; Nikfar S; Abdollahi M
    Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
    [TBL] [Abstract][Full Text] [Related]  

  • 46. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study.
    Guandalini S; Magazzù G; Chiaro A; La Balestra V; Di Nardo G; Gopalan S; Sibal A; Romano C; Canani RB; Lionetti P; Setty M
    J Pediatr Gastroenterol Nutr; 2010 Jul; 51(1):24-30. PubMed ID: 20453678
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial.
    Madisch A; Holtmann G; Plein K; Hotz J
    Aliment Pharmacol Ther; 2004 Feb; 19(3):271-9. PubMed ID: 14984373
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of a Chinese Herbal Medicine in Providing Adequate Relief of Constipation-predominant Irritable Bowel Syndrome: A Randomized Controlled Trial.
    Bensoussan A; Kellow JE; Bourchier SJ; Fahey P; Shim L; Malcolm A; Boyce P
    Clin Gastroenterol Hepatol; 2015 Nov; 13(11):1946-54.e1. PubMed ID: 26133902
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel medications for the irritable bowel syndrome: motility and sensation.
    Camilleri M
    J Pediatr Gastroenterol Nutr; 2001; 32 Suppl 1():S35-7. PubMed ID: 11321419
    [No Abstract]   [Full Text] [Related]  

  • 50. Hypersensitivity and hyperreactivity in the irritable bowel syndrome: An opportunity for drug discovery.
    Sanger GJ
    Dig Dis; 1999; 17(2):90-9. PubMed ID: 10545714
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of pinaverium bromide in south Indian patients with irritable bowel syndrome.
    Jayanthi V; Malathi S; Ramathilakam B; Dinakaran N; Balasubramanian V; Mathew S
    J Assoc Physicians India; 1998 Apr; 46(4):369-71. PubMed ID: 11273320
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical trial: dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syndrome.
    Leventer SM; Raudibaugh K; Frissora CL; Kassem N; Keogh JC; Phillips J; Mangel AW
    Aliment Pharmacol Ther; 2008 Jan; 27(2):197-206. PubMed ID: 17973974
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microencapsulated sodium butyrate reduces the frequency of abdominal pain in patients with irritable bowel syndrome.
    Banasiewicz T; Krokowicz Ł; Stojcev Z; Kaczmarek BF; Kaczmarek E; Maik J; Marciniak R; Krokowicz P; Walkowiak J; Drews M
    Colorectal Dis; 2013 Feb; 15(2):204-9. PubMed ID: 22738315
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Mechanism of action of trimebutine maleate on gastro-colic reflex in patients with irritable bowel syndrome].
    Matsue T; Yamato S; Umeda N
    Nihon Heikatsukin Gakkai Zasshi; 1990 Apr; 26(2):89-92. PubMed ID: 2273694
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical trial: renzapride treatment of women with irritable bowel syndrome and constipation - a double-blind, randomized, placebo-controlled, study.
    Lembo AJ; Cremonini F; Meyers N; Hickling R
    Aliment Pharmacol Ther; 2010 May; 31(9):979-90. PubMed ID: 20163375
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of ramosetron on stool consistency in male patients with irritable bowel syndrome with diarrhea.
    Fukudo S; Ida M; Akiho H; Nakashima Y; Matsueda K
    Clin Gastroenterol Hepatol; 2014 Jun; 12(6):953-9.e4. PubMed ID: 24315882
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical and functional evaluation of the efficacy of otilonium bromide: a multicenter study in Italy.
    Baldi F; Longanesi A; Blasi A; Monello S; Cestari R; Missale G; Corazziari E; Badiali G; Pescatori M; Anastasio G
    Ital J Gastroenterol; 1991 Nov; 23(8 Suppl 1):60-3. PubMed ID: 1756285
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acupuncture treatment for irritable bowel syndrome. A double-blind controlled study.
    Fireman Z; Segal A; Kopelman Y; Sternberg A; Carasso R
    Digestion; 2001; 64(2):100-3. PubMed ID: 11684823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine.
    Lee KJ; Kim NY; Kwon JK; Huh KC; Lee OY; Lee JS; Choi SC; Sohn CI; Myung SJ; Park HJ; Choi MK; Bak YT; Rhee PL
    Neurogastroenterol Motil; 2011 Dec; 23(12):1098-104. PubMed ID: 21920001
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Efficacy of alverina citrate and simethicone combination in abdominal pain and discomfort of irritable bowel syndrome].
    Wittmann T; Paradovsky L; Ducrotte P; Bueno L; Andro-Delestrain MC
    Eksp Klin Gastroenterol; 2011; (3):60-7. PubMed ID: 21698811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.